EXOSKELETON MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America dominates the global exoskeleton market with an estimated 35.8% share in 2024, owing to strong presence of major exoskeleton manufacturers in the region. The U.S. houses headquarters of leading players like Ekso Bionics, Parker Hannifin, Rex Bionics, and Suit X which are extensively focusing on developing advanced exoskeleton solutions for healthcare and military applications. Moreover, large defense spending and continuous technological advancements in the country support product development activities.

Additionally, rising venture capital investments in exoskeleton startups have accelerated commercialization of various prototypes. The region is also an early adopter of exoskeleton technologies due to growing geriatric population and rising prevalence of diseases like stroke that limit mobility. Leading healthcare providers are actively pursuing clinical trials to evaluate benefits of exoskeleton-assisted therapy.

On the other hand, Asia Pacific  exoskeleton market is growing at the fastest pace and emerging as a major hub for exoskeleton manufacturing. Countries like China, Japan, South Korea, and India are aggressively investing in exoskeleton R&D activities to gain competitive edge in global trade. For example, the “Made in China 2025” strategy focuses on promoting local production of medical robots and assistive devices including exoskeletons. This has attracted global players to establish joint ventures with local manufacturers to leverage low labor costs and tap into the huge patient population in Asia Pacific region.

China in particular has emerged as the top exporter of low-cost exoskeleton components due to wide presence of electronics and automotive component suppliers. Considerable difference in pricing of exoskeleton systems in Asia Pacific compared to other regions is another factor fueling sales growth. Additionally, Asia Pacific countries are witnessing rapid aging which is anticipated to significantly drive the demand for exoskeleton-assisted rehabilitation and care in the coming years.